We are live on ! Find out more
MNG

Manning & Napier Group Portfolio holdings

AUM $8.76B
1-Year Est. Return 23.27%
This Fund
S&P 500
This Quarter Est. Return
+11.67%
1 Year Est. Return
+23.27%
3 Year Est. Return
+31.12%
5 Year Est. Return
+100.85%
10 Year Est. Return
AUM
$8.42B
AUM Growth
+$351M
Cap. Flow
-$536M
Cap. Flow %
-6.36%
Top 10 Hldgs %
28.16%
Holding
239
New
4
Increased
32
Reduced
151
Closed
9

Sector Composition

1 Healthcare 18.31%
2 Technology 14.56%
3 Financials 14.54%
4 Industrials 12.58%
5 Communication Services 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
1
Amazon
AMZN
$2.67T
$333M 3.96%
2,193,666
-69,679
-3% -$9.77M
MA icon
2
Mastercard
MA
$479B
$265M 3.15%
622,034
-10,354
-2% -$4.16M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.23T
$259M 3.07%
1,850,602
+63,197
+4% +$8.49M
JNJ icon
4
Johnson & Johnson
JNJ
$614B
$255M 3.02%
1,624,400
-62,582
-4% -$9.6M
MU icon
5
Micron Technology
MU
$964B
$248M 2.95%
2,908,233
-183,934
-6% -$13.7M
LHX icon
6
L3Harris
LHX
$53.6B
$223M 2.65%
1,061,144
+26,968
+3% +$5.06M
V icon
7
Visa
V
$682B
$204M 2.42%
783,398
-36,128
-4% -$8.9M
META icon
8
Meta Platforms (Facebook)
META
$1.6T
$199M 2.37%
562,698
-316,448
-36% -$103M
TSM icon
9
TSMC
TSM
$2.05T
$196M 2.33%
1,884,742
+543,083
+40% +$51.8M
EA icon
10
Electronic Arts
EA
$52.4B
$189M 2.24%
1,377,849
-28,162
-2% -$3.72M
AZN icon
11
AstraZeneca
AZN
$263B
$187M 2.22%
1,389,606
+1,025,032
+281% +$133M
KO icon
12
Coca-Cola
KO
$357B
$186M 2.21%
3,155,240
-23,207
-0.7% -$1.32M
UL icon
13
Unilever
UL
$135B
$162M 1.92%
2,962,626
+42,006
+1% +$2.27M
MCO icon
14
Moody's
MCO
$88.9B
$156M 1.85%
399,810
-18,808
-4% -$6.54M
MSFT icon
15
Microsoft
MSFT
$2.91T
$140M 1.67%
373,220
+971
+0.3% +$346K
FMC icon
16
FMC
FMC
$1.42B
$139M 1.65%
2,202,668
-46,965
-2% -$2.72M
NOW icon
17
ServiceNow
NOW
$107B
$132M 1.57%
935,285
-561,525
-38% -$70.8M
MDT icon
18
Medtronic
MDT
$107B
$126M 1.5%
1,534,010
-785,820
-34% -$59.9M
EVRG icon
19
Evergy
EVRG
$20.1B
$114M 1.35%
2,183,788
+947,196
+77% +$47.7M
IDXX icon
20
Idexx Laboratories
IDXX
$44.9B
$113M 1.34%
202,983
-4,012
-2% -$1.88M
BMRN icon
21
BioMarin Pharmaceuticals
BMRN
$11.6B
$110M 1.31%
1,145,113
+6,161
+0.5% +$545K
MAS icon
22
Masco
MAS
$16.1B
$107M 1.27%
1,602,738
-1,109,772
-41% -$64.5M
UNP icon
23
Union Pacific
UNP
$179B
$107M 1.27%
435,311
-26,028
-6% -$5.72M
NVS icon
24
Novartis
NVS
$295B
$107M 1.27%
1,057,168
-12,025
-1% -$1.16M
ICE icon
25
Intercontinental Exchange
ICE
$79.5B
$106M 1.25%
822,330
+146,170
+22% +$16.6M

Similar funds

Manning & Napier Group's Q4 2023 Portfolio in Review

As of Q4 2023, Manning & Napier Group held 239 positions worth $8.42B, up 4.4% from $8.07B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Manning & Napier Group withdrew a net $536M in Q4 2023, closing 9 positions and reducing 151 holdings. Its most notable exit was RenaissanceRe, an estimated $24.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

Against the trend, Manning & Napier Group opened a new position in Crown Castle worth $5.01M.

  • Manning & Napier Group's largest Q4 2023 buy was Crown Castle: 43,450 shares worth $5.01M.
  • Manning & Napier Group added most to AstraZeneca in Q4 2023, an estimated $133M increase.
  • Manning & Napier Group's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $103M.
  • Manning & Napier Group fully exited RenaissanceRe in Q4 2023, selling an estimated $24.3M.
  • Manning & Napier Group's ten largest holdings make up 28% of its $8.42B portfolio in Q4 2023.
  • Manning & Napier Group opened 4 new positions and closed 9 in Q4 2023.
  • Manning & Napier Group's portfolio value rose 4.4% quarter-over-quarter to $8.42B.

Based on Manning & Napier Group's 13F filing for Q4 2023, filed 19 Jan 2024.